David Malcom Rodman, Chief Medical Officer, on May 11, 2026, sold 22,575 shares in Mineralys Therapeutics (MLYS) for $652,638. Following the Form 4 filing with the SEC, Rodman has control over a total of 63,443 common shares of the company, with 63,443 shares held directly.
SEC Filing: